{"id":"NCT01516736","sponsor":"Sandoz","briefTitle":"Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim","officialTitle":"Pivotal Study in Breast Cancer Patients Investigating Efficacy and Safety of LA-EP2006 and Neulasta®","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-03","primaryCompletion":"2013-08","completion":"2013-12","firstPosted":"2012-01-25","resultsPosted":"2017-06-28","lastUpdate":"2017-08-30"},"enrollment":308,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"SUPPORTIVE_CARE"},"conditions":["Chemotherapy-induced Neutropenia","Breast Cancer"],"interventions":[{"type":"DRUG","name":"LA-EP2006","otherNames":["pegfilgrastim"]},{"type":"DRUG","name":"Neulasta®","otherNames":["pegfilgrastim","Neulasta"]}],"arms":[{"label":"LA-EP2006","type":"EXPERIMENTAL"},{"label":"Neulasta®","type":"ACTIVE_COMPARATOR"}],"summary":"The study will assess the efficacy of LA-EP2006 compared to Neulasta® with respect to the mean duration of severe neutropenia during treatment with myelosuppressive chemotherapy in breast cancer patients.","primaryOutcome":{"measure":"Mean Duration of Severe Neutropenia (DSN) During Cycle 1 of Chemotherapy","timeFrame":"21 days (Cycle 1 of chemotherapy treatment)","effectByArm":[{"arm":"LA-EP2006","deltaMin":1.36,"sd":1.133},{"arm":"Neulasta®","deltaMin":1.19,"sd":0.984}],"pValues":[{"comp":"OG000 vs OG001","p":"0.05"},{"comp":"OG000 vs OG001","p":"0.05"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":4},"locations":{"siteCount":53,"countries":["United States","Argentina","Chile","India","Malaysia","Puerto Rico","Russia","Spain"]},"refs":{"pmids":["27091420","28637287"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":29,"n":155},"commonTop":["Gastrointestinal disorders","General disorders and administration site conditions","Skin and subcutaneous tissue disorders","Blood and lymphatic system disorders","Musculoskeletal and connective tissue disorders"]}}